Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future

被引：0
|
作者：
Rajappan, Kim [1 ]
机构：
[1] John Radcliffe Hosp, Dept Cardiac, Oxford OX3 9DU, England
来源：
HEART | 2013年 / 99卷 / 06期
关键词：
RISK; WARFARIN;
D O I：
10.1136/heartjnl-2012-302762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [41] Novel Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: Dawn of a New Era
    Contractor, Tahmeed
    Levin, Vadim
    Martinez, Matthew W.
    Marchlinski, Francis E.
    POSTGRADUATE MEDICINE, 2013, 125 (01) : 34 - 44
  • [42] Novel oral anticoagulants to prevent stroke in atrial fibrillation
    Freek W. A. Verheugt
    Nature Reviews Cardiology, 2010, 7 : 149 - 154
  • [43] Novel oral anticoagulants to prevent stroke in atrial fibrillation
    Verheugt, Freek W. A.
    NATURE REVIEWS CARDIOLOGY, 2010, 7 (03) : 149 - 154
  • [44] Stroke prevention in atrial fibrillation. Old and new anticoagulants
    Darius, H.
    Sommer, S.
    HERZ, 2013, 38 (03) : 231 - +
  • [45] Prevention of stroke in patients with atrial fibrillation: a role of modern anticoagulants
    Anisimova, A. V.
    Gendlin, G. E.
    Borisov, S. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (09) : 62 - 69
  • [46] Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillation
    Kampouraki, Emmanouela
    Kamali, Farhad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (06) : 449 - 458
  • [47] Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation
    Baker, D.
    Wilsmore, B.
    Narasimhan, S.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (07) : 792 - 797
  • [48] Cos Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Kim, Hyunmee
    Kim, Hyeongsoo
    Cho, Seong-Kyung
    Kim, Jin-Bae
    Joung, Boyoung
    Kim, Changsoo
    KOREAN CIRCULATION JOURNAL, 2019, 49 (03) : 252 - 263
  • [49] Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer
    Laube, Eva S.
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen
    Soff, Gerald A.
    Mantha, Simon
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (02): : 213 - 217
  • [50] Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
    Mensch, Alexander
    Stock, Stephanie
    Stollenwerk, Bjoern
    Mueller, Dirk
    PHARMACOECONOMICS, 2015, 33 (03) : 271 - 283
12345